Novophage is providing the next generation of antimicrobials for environmental and industrial biofilm contaminations. Biofilms, slimy communities of bacteria, cause biofouling, corrosion, energy inefficiency, diseases and $ 22B in annual costs. Current treatments are toxic, corrosive and environmentally damaging. Novophage has developed a first-in-class anti-biofilm solution that is green and highly effective against biofilms. Novophage's solution is enabled by expertise in synthetic biology and systems biology and can be combined with existing antimicrobials to eradicate industrial and environmental biofilms, a $ 2.2B market.